[Radiation therapy of malignant neoplasms of the middle ear after nonradical surgical interventions].
The paper is concerned with the short- and long-term results of gamma-beam therapy and chemo- and radiotherapy in 109 patients with malignant middle ear tumors after nonradical surgical interventions. A single focal dose was 2-2.5 Gy, a summary dose varied within 60-80 Gy with relation to the degree of dissemination, growth type and tumor histological structure. A 3-year survival rate was 41.1%, a 5-year survival rate was 21%.
D000328:Adult; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004428:Ear Neoplasms / Q000401:mortality / Q000532:radiotherapy* / Q000601:surgery; D004432:Ear, Middle; D005260:Female; D005720:Gamma Rays / Q000627:therapeutic use; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D011182:Postoperative Care / Q000379:methods*; D011879:Radiotherapy Dosage; D013852:Thiotepa / Q000008:administration & dosage
D003520:Cyclophosphamide; D013852:Thiotepa
Luchevaia terapiia zlokachestvennykh novoobrazovaniĭ srednego ukha posle neradikal'nykh khirurgicheskikh vmeshatel'stv.